NCT02776748View on ClinicalTrials.gov

PrEP in Breastfeeding Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

December 31, 2015

Conditions
HIV Pre-exposure Prophylaxis During Breastfeeding
Interventions
DRUG

FTC/TDF PrEP

Daily oral directly observed FTC/TDF PrEP administered to breastfeeding HIV-uninfected women

Trial Locations (2)

Unknown

Partners in Prevention-Thika, Thika

Partners in Prevention-Infectious Diseases Institute LTD, Kampala

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

lead

University of Washington

OTHER

NCT02776748 - PrEP in Breastfeeding Study | Biotech Hunter | Biotech Hunter